208 related articles for article (PubMed ID: 4076027)
1. A comparative study of two antispasmodic products: Buscopan and NO-Spa.
Maitai CK; Njoroge DK; Munenge RW
East Afr Med J; 1985 Jul; 62(7):480-5. PubMed ID: 4076027
[No Abstract] [Full Text] [Related]
2. [Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].
Makarchuk PA
Eksp Klin Gastroenterol; 2007; (6):126-9. PubMed ID: 18418922
[No Abstract] [Full Text] [Related]
3. [Study of a new synthetic spasmolytic (DA 3177) in emergency medicine].
Del Fabbro L; Di Bartolomeo C; Grassi L; Lestuzzi A; Perraro F; Tosolini G
Clin Ter; 1977 Dec; 83(6):609-23. PubMed ID: 343975
[No Abstract] [Full Text] [Related]
4. [Results of treatments with the phytopharmaceuticals bilicura and spasmobilicura in disorders of the liver-bile-digestive system].
Gracza L; Gracza E
Fortschr Med; 1977 Dec; 95(47-48):2829-31. PubMed ID: 590909
[No Abstract] [Full Text] [Related]
5. Efficacy of peppermint oil as an antispasmodic during endoscopic retrograde cholangiopancreatography.
Yamamoto N; Nakai Y; Sasahira N; Hirano K; Tsujino T; Isayama H; Komatsu Y; Tada M; Yoshida H; Kawabe T; Hiki N; Kaminishi M; Kurosaka H; Omata M
J Gastroenterol Hepatol; 2006 Sep; 21(9):1394-8. PubMed ID: 16911682
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial use of No-Spa+lidocaine in coxarthrosis.
Tantó Z; Molnár L; Kálózdi T; Maros M; Várhelyi M
Ther Hung; 1982; 30(3):134-6. PubMed ID: 6765332
[No Abstract] [Full Text] [Related]
7. [Current potentialities of Buscopan in clinical practice].
Sheptulin AA
Klin Med (Mosk); 1997; 75(8):55-7. PubMed ID: 9340442
[No Abstract] [Full Text] [Related]
8. [Effect of scopolamine butylbromide on injury of microvessels in bone marrow].
Tian N
Zhonghua Yi Xue Za Zhi; 1988 Sep; 68(9):494-6, 34. PubMed ID: 3228749
[No Abstract] [Full Text] [Related]
9. Routine use of hyoscine N butylbromide (Buscopan) in double contrast barium enema examinations.
Lee JR
Clin Radiol; 1982 May; 33(3):273-6. PubMed ID: 7075130
[TBL] [Abstract][Full Text] [Related]
10. Importance of No-Spa and Probon combination in the conservative treatment of ureterolithiasis patients.
Vecsey D
Ther Hung; 1984; 32(3):127-9. PubMed ID: 6571196
[No Abstract] [Full Text] [Related]
11. [Use of Dolispan in the system of managing labor].
Iarukov L; Shturkalev I; Iordanov G; Khadzhiev A
Akush Ginekol (Sofiia); 1977; 16(1):8-18. PubMed ID: 324305
[No Abstract] [Full Text] [Related]
12. [Manometric evaluation of the effects of intravenous administration of glucagon, buscopan and papaverine on the contractile activity of the sphincter of Oddi].
Kaczor R; Nowak A; Nowakowska-Duława E; Rybicka J
Pol Arch Med Wewn; 1992 Feb; 87(2):96-103. PubMed ID: 1523144
[TBL] [Abstract][Full Text] [Related]
13. Examination of the pain relieving-effect of intra-arterial No-Spa treatment of coxarthrosis.
Barta O; Temesi M; Varró J
Ther Hung; 1982; 30(2):79-82. PubMed ID: 6926909
[No Abstract] [Full Text] [Related]
14. The influence of buscopan on adverse reactions to intravascular contrast media.
Sharma S; Rajani M; Khosla A; Misra N; Goulatia RK
Br J Radiol; 1989 Dec; 62(744):1056-8. PubMed ID: 2605452
[TBL] [Abstract][Full Text] [Related]
15. [Drug information: buscopan compositum].
Perspectivas; 1979; 4(4):39-41. PubMed ID: 261805
[No Abstract] [Full Text] [Related]
16. Buscopan for oesophageal food bolus impaction.
Anderson R; Lee J
Emerg Med J; 2007 May; 24(5):360-1. PubMed ID: 17452709
[No Abstract] [Full Text] [Related]
17. [Clinical use of the spasmolytic, buscopan].
Ned Tijdschr Geneeskd; 1955 Jun; 99(26):1940-7. PubMed ID: 13244736
[No Abstract] [Full Text] [Related]
18. [Experiences with buscopan, a spasmolytic, in urology].
BAUER K
Med Welt (Stuttg); 1951 Oct; 20(43):1351-3. PubMed ID: 14899360
[No Abstract] [Full Text] [Related]
19. [Sodium diclofenac in the treatment of biliary pain: a controlled study using hyoscine N-butylbromide].
Rossi PC; Giudicelli N; Parenti G; Pacetti E
Clin Ter; 1988 Sep; 126(6):405-10. PubMed ID: 2974401
[No Abstract] [Full Text] [Related]
20. Bronchospasmolytic effect of oxitropium bromide following powder inhalation in anaesthetized dogs.
Traunecker W
Arzneimittelforschung; 1988 Nov; 38(11):1623-4. PubMed ID: 3214446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
